Exodus Point Capital Management, LP Incyte Corp Transaction History

Exodus Point Capital Management, LP

$16.4 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$57.77 - $65.93 $6.14 Million - $7.01 Million	106,282 Added 810.69%	119,392 $6.9 Million
Q2 2023 Aug 10, 2023	SELL	$60.95 - $75.51 $2.76 Million - $3.42 Million	-45,234 Reduced 77.53%	13,110 $816,000
Q1 2023 May 11, 2023	BUY	$70.23 - $86.01 $4.1 Million - $5.02 Million	58,344 New	58,344 $4.22 Million
Q3 2022 Nov 10, 2022	BUY	$66.18 - $82.86 $1.39 Million - $1.74 Million	20,982 New	20,982 $1.4 Million
Q2 2022 Aug 19, 2022	SELL	$66.18 - $83.18 $6.61 Million - $8.31 Million	-99,910 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$66.02 - $79.71 $3.25 Million - $3.93 Million	49,249 Added 97.21%	99,910 $7.94 Million
Q4 2021 Feb 11, 2022	BUY	$63.34 - $74.11 $2.96 Million - $3.46 Million	46,677 Added 1171.61%	50,661 $3.72 Million
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $1.56 Million - $1.9 Million	-22,650 Reduced 85.04%	3,984 $274,000
Q2 2021 Aug 16, 2021	BUY	$79.87 - $87.53 $2.13 Million - $2.33 Million	26,634 New	26,634 $2.24 Million
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $362,691 - $479,485	-4,771 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $385,210 - $466,126	4,771 New	4,771 $415,000
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $330,916 - $485,936	-4,461 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $1.46 Million - $1.99 Million	-23,169 Reduced 83.85%	4,461 $327,000
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $2.02 Million - $2.64 Million	27,630 New	27,630 $2.41 Million
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $1.25 Million - $1.49 Million	-17,172 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $502,288 - $605,998	6,832 Added 66.07%	17,172 $1.46 Million
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $657,210 - $911,677	10,340 New	10,340 $889,000

Others Institutions Holding INCY

# of Institutions

644

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account